Sign in

KBLB on OTC

Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. is an American plastic material company that raised $8 million in 2020 (SEC Form D).1 It is headquartered in Ann Arbor, Michigan.1 Its shares trade on OTC under the symbol KBLB.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Sealed Air, Celanese Corporation or EIDP, or pick any stock.

  • TickerKBLB on OTC1
  • IndustryPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)1
  • HeadquartersAnn Arbor, Michigan1
  • Incorporated inWY2
  • Business address2723 South State Street, Suite 150, Ann Arbor, Mi 481042
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income345678-$3.4M in 2025+29% since 2019
-$6.0M-$4.0M-$2.0M02019: -$2.6M-$2.6M20192020: -$4.5M-$4.5M2020+73%2021: -$2.8M-$2.8M2021−39%2022: -$2.1M-$2.1M2022−23%2023: -$2.6M-$2.6M2023+23%2024: -$3.1M-$3.1M2024+18%2025: -$3.4M-$3.4M2025+10%
Net income345678-$3.6M in 2025+25% since 2019
-$10.0M-$7.5M-$5.0M-$2.5M02019: -$2.9M-$2.9M20192020: -$5.0M-$5.0M2020+71%2021: -$8.0M-$8.0M2021+62%2022: -$3.8M-$3.8M2022−52%2023: -$3.0M-$3.0M2023−21%2024: -$3.4M-$3.4M2024+12%2025: -$3.6M-$3.6M2025+7%

Every line of the income statement as filed: the last 2 fiscal years, latest first.8

Period ending2025-12-312024-12-31
General and Administrative$2.0M$1.7M
Professional Fees$379.2K$290.3K
Officers Salary$871.0K$872.3K
Research and Development$165.8K$164.4K
Total Operating Expenses$3.4M$3.1M
Loss from Operations-$3.4M-$3.1M
Net change in unrealized apreciation on investment in gold bullion$110.2K$133.8K
Interest expense-$570.7K-$529.6K
Gain on sale of gold$200.4K
Interest income$11.5K$71.4K
Total Other Income/(Expenses)-$248.6K-$324.4K
Net (Loss) before Provision for Income Taxes-$3.6M-$3.4M
Net (Loss)-$3.6M-$3.4M
Net Income (Loss) Per Share - Basic$0.00$0.00
Net Income (Loss) Per Share - Diluted$0.00$0.00
Weighted average number of shares outstanding during the period - Basic1.1B shares1.0B shares
Weighted average number of shares outstanding during the period - Diluted1.1B shares1.0B shares

Compare Kraig Biocraft Laboratories, Inc. with another company

What it owns

What Kraig Biocraft Laboratories, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Accumulated depreciation$245.1K8 Dec 31, 2025$221.6K8 Dec 31, 2024+10.6%
Property and equipment, net$25.0K8 Dec 31, 2025$44.7K8 Dec 31, 2024−44.1%
Operating-lease assets (leased space)$170.5K8 Dec 31, 2025$86.1K8 Dec 31, 2024+98.0%

Real estate and locations

ItemLatestA year beforeChange
Area of land80 sq ft8 Sep 20, 20245,000 sq ft8 Sep 5, 2019−98.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.8M8 Dec 31, 2025$673.3K8 Dec 31, 2024+165.9%
Marketable securities, current$08 Dec 31, 2025$08 Dec 31, 2024

Inventory

ItemLatestA year beforeChange
Inventory, total$29.1K8 Dec 31, 2025$6.9K8 Dec 31, 2024+322.2%

Properties, in its own words

Our principal executive office is located at 2723 South State St., Suite 150, Ann Arbor, Michigan. We pay an annual rent of $3,048 for conference facilities, mail, fax, and reception services located at this location.

On September 5, 2019, we signed a two-year lease for a 5,000 square foot property in Lansing, MI that commenced on October 1, 2019, and ends on September 30, 2021, for its research and development headquarters. Pursuant to the lease, it was an annual rent of $42,000 for year one of the lease and $44,800 for year two of the lease. On April 16, 2021, we signed a two-year amendment to this lease, pursuant to which, commencing on July 1, 2021, and ending on September 30, 2022, we pay an annualized rent of $42,000 and from October 1, 2022, through September 30, 2023, we will pay an annual rent of $44,800. On October 1, 2023, the Company extended the terms of the lease through September 30, 2025. From October 1, 2023, through September 30, 2024, the Company will pay an annual rent of $44,800. From October 1, 2024, through September 30, 2025, the Company will pay an annual rent of $47,600. On October 1, 2025, the Company extended the terms of the lease through September 30, 2028.

The rest of Item 2

On July 1, 2021, the Company signed a 5-year property lease in the Socialist Republic of Vietnam which consists of 30,000 square meters of property and 6,000 square meter of buildings, which it leases at a rate of approximately $8,645 per year for each of the five years. In 2025 the Company ended this lease.

On January 31, 2024, the Company signed a five-year lease for a 700 square meter facility in Lam Dong, Vietnam that commenced on February 1, 2024, and ends on January 31, 2029. We were scheduled to pay an annual rent of approximately $7,284 for year one and two of the lease. During the third quarter of 2024, the Company terminated its ROU lease arrangement. The Company does not occupy or use the facility and therefore has determined to impair this asset as there is no future benefit.

On September 20, 2024, the Company signed a six-year lease for an 80 square meter facility in Lam Dong, Vietnam that commenced on September 20, 2024, and ends on December 31, 2030. We pay an annual rent of approximately $7,200 for year one and two of the lease, $7,920 for year three, and $8,712 for years four through six.

Item 2 of the 10-K filed Mar 30, 2026.13

Leadership

Who has led Kraig Biocraft Laboratories, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Kimberly Kraig Thompson2020–now

Chief financial officer

  1. Kimberly Kraig Thompson2020–2022
2025
Board members and other officers (1)

Former names

  • Kraig Biocraft Laboratories, IncSep 26, 2007 to May 20, 20252

Timeline

  1. Feb 18, 20268-K Other events15
  2. Jan 21, 20258-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure16
  3. Apr 1, 20248-K Unregistered sale of shares17
  4. Apr 12, 20228-K Entered a material agreement; New debt or obligation18
  5. Jan 20, 20228-K Entered a material agreement; New debt or obligation; Other events19
  6. Dec 23, 2020New chief executive Kimberly Kraig Thompson becomes CEO14

Filings

123 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 5 major events, 33 insider forms, 1 private raises, 64 other. The latest 20:

  1. Aug 13, 202610-Q EDGAR
  2. May 22, 2026424B3 EDGAR
  3. May 22, 2026424B3 EDGAR
  4. May 22, 2026424B3 EDGAR
  5. May 14, 202610-Q EDGAR
  6. May 14, 2026424B3 EDGAR
  7. May 14, 2026424B3 EDGAR
  8. May 13, 2026EFFECT EDGAR
  9. May 11, 2026POS AM EDGAR
  10. Apr 30, 2026424B3 EDGAR
  11. Apr 28, 2026EFFECT EDGAR
  12. Apr 21, 2026POS AM EDGAR
  13. Mar 30, 202610-K EDGAR
  14. Feb 18, 20268-K EDGAR
  15. Nov 17, 2025424B3 EDGAR
  16. Nov 17, 2025424B3 EDGAR
  17. Nov 12, 202510-Q EDGAR
  18. Aug 18, 2025424B3 EDGAR
  19. Aug 18, 2025424B3 EDGAR
  20. Aug 18, 2025424B3 EDGAR

The 123 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

44 open-market trades by officers, directors and large owners since October 2021: 0 buys and 44 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 20, 2022Thompson Kimberly KraigChief Executive OfficerSale120,000Form 4
Jul 19, 2022Thompson Kimberly KraigChief Executive OfficerSale50,000Form 4
Jul 18, 2022Thompson Kimberly KraigChief Executive OfficerSale79,900Form 4
Jul 15, 2022Thompson Kimberly KraigChief Executive OfficerSale50,000Form 4
Jul 13, 2022Thompson Kimberly KraigChief Executive OfficerSale11,500Form 4
Jul 11, 2022Thompson Kimberly KraigChief Executive OfficerSale100,000Form 4
Jul 8, 2022Thompson Kimberly KraigChief Executive OfficerSale40,000Form 4
Jul 7, 2022Thompson Kimberly KraigChief Executive OfficerSale20,000Form 4
Jul 6, 2022Thompson Kimberly KraigChief Executive OfficerSale60,000Form 4
Jul 5, 2022Thompson Kimberly KraigChief Executive OfficerSale20,000Form 4
Jun 29, 2022Thompson Kimberly KraigChief Executive OfficerSale20,000Form 4
Jun 28, 2022Thompson Kimberly KraigChief Executive OfficerSale30,000Form 4
Jun 27, 2022Thompson Kimberly KraigChief Executive OfficerSale50,000Form 4
Jun 24, 2022Thompson Kimberly KraigChief Executive OfficerSale30,000Form 4
Jun 23, 2022Thompson Kimberly KraigChief Executive OfficerSale80,000Form 4
Jun 22, 2022Thompson Kimberly KraigChief Executive OfficerSale30,000Form 4
Jun 21, 2022Thompson Kimberly KraigChief Executive OfficerSale180,000Form 4
Jun 17, 2022Thompson Kimberly KraigChief Executive OfficerSale100,000Form 4
Jun 15, 2022Thompson Kimberly KraigChief Executive OfficerSale10,000Form 4
Jun 8, 2022Thompson Kimberly KraigChief Executive OfficerSale20,000Form 4

All 44 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Dec 11, 2020Raised $8 million in a private offering of securities Form D: 1 investor so far Form D

SEC filer profile

How Kraig Biocraft Laboratories, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARKraig Biocraft Laboratories, Inc.1
  • CIK0001413119
  • Employer ID (EIN)83-045970713
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company13
  • Incorporated inWyoming13
  • Fiscal year endsDecember 311
  • Industry code (SIC)2820 Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address2723 South State Street, Suite 150, Ann Arbor, MI 481041
  • Phone(734) 619-80661
  • Shares outstanding1,099,791,733 shares as of Mar 30, 202613
  • Public float$88.9M as of Jun 30, 202513
  • AuditorM&K CPAS, PLLC, The Woodlands, TX PCAOB ID 2738; no auditor attestation of internal control over financial reporting13
  • On EDGAR sinceSep 26, 20071
  • Filings384 in all: 4 (79), 10-Q (56), 424B3 (36), S-1/A (33), 8-K (32), CORRESP (20), UPLOAD (19), 10-K (18)1
    All 30 form types

    EFFECT (18), POS AM (14), NT 10-Q (12), 10-Q/A (10), S-1 (8), NT 10-K (6), 10-K/A (4), 8-K/A (4), 3 (2), 10KSB (1), 10QSB (1), 424B1 (1), 5 (1), 8-A12G (1), AW (1), D (1), DEF 14C (1), PRE 14C (1), REGDEX (1), SB-2 (1), SC 13D (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (10-K) Mar 30, 2026
    Quarterly report (10-Q) Aug 13, 2026
    Latest 8-K (8-K) Feb 18, 2026

Risk factors and legal proceedings

Legal proceedings

We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.

To the knowledge of our management, we are currently not a party to any material legal or administrative proceedings and are not aware of any pending or threatened legal or administrative proceedings against us.

The opening of Item 3, Legal Proceedings.13

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
    SEC EDGAROther events
  16. 16
  17. 17
  18. 18
  19. 19